Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.

por Visser, C. J., de Weger, R. A., van Blokland, W. T., Seifert-Bock, I., Kobrin, M. S., Korc, M., Woutersen, R. A.
Publicado 1996

Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses

por de Haart, S J, Willems, S M, Mutis, T, Koudijs, M J, van Blokland, M T, Lokhorst, H M, de Weger, R A, Minnema, M C
Publicado 2016

Clinical versus histological grading in the assessment of cutaneous graft versus host disease

por Hogenes, M. C. H., te Boome, L. C. J., van der Valk, D. C., van Dijk, M. R., de Weger, R. A., Kuball, J., van Diest, P. J.
Publicado 2019

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.

por Vooijs, W. C., Otten, H. G., van Vliet, M., van Dijk, A. J., de Weger, R. A., de Boer, M., Bohlen, H., Bolognesi, A., Polito, L., de Gast, G. C.
Publicado 1997

Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value

por Lok, S. I., Lok, D. J., van der Weide, P., Winkens, B., Bruggink-André de la Porte, P. W., Doevendans, P. A., de Weger, R. A., van der Meer, P., de Jonge, N.
Publicado 2014

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)

por Ubink, I., Bloemendal, H. J., Elias, S. G., Brink, M. A., Schwartz, M. P., Holierhoek, Y. C. W., Verheijen, P. M., Boerman, A. W., Mathijssen, R. H. J., de Leng, W. W. J., de Weger, R. A., van Grevenstein, W. M. U., Koopman, M., Lolkema, M. P., Kranenburg, O., Borel Rinkes, I. H. M.
Publicado 2017